Kotak fund invests Rs.1,050-Cr in nutraceutical maker Tirupati Medicare; Affirma Capital exits
Kotak Alternate Asset Managers has invested INR 1,050 crore in Delhi-based pharma company Tirupati Medicare . The investment also gives a complete exit to Affirma Capital.The 2005-founded Tirupati is the largest players in the nutraceutical contract manufacturing space, serving customers like Herbalife, Glanbia, Abbott, Torrent, Dr Reddy's, and Pfizer, among others.
In Aug-19, Tirupati had attracted about USD 50 M from Affirma Capital.
Want to receive such news items in your inbox? Click Here to sign up for a trial.